What is BioInetlli?
BioInetlli operates as a critical intelligence provider, specializing in proprietary algorithms and comprehensive database solutions tailored for the life science business market. The company serves as an essential conduit for organizations seeking to optimize sales and marketing efforts across diverse sectors, including government agencies, private biopharma, academic research institutions, and venture capital firms. By synthesizing complex datasets into actionable insights, BioInetlli enables stakeholders to navigate the intricate landscape of life science funding and research development with unprecedented precision. Its platform acts as a foundational tool for entities aiming to streamline their outreach and identify high-value opportunities within the global scientific community.
How much funding has BioInetlli raised?
BioInetlli has raised a total of $262K across 3 funding rounds:
Debt
$20K
Debt
$122K
Debt
$120K
Debt (2021): $20K with participation from PPP
Debt (2025): $122K led by Northeast Bank
Debt (2026): $120K supported by Northeast Bank
Key Investors in BioInetlli
Northeast Bank
A financial institution providing commercial banking services and debt financing solutions to support corporate growth and operational stability.
PPP
Public-Private Partnership
What's next for BioInetlli?
With the recent infusion of capital, BioInetlli is well-positioned to scale its operational capacity and enhance its algorithmic capabilities. The strategic focus will likely shift toward expanding its database coverage and integrating advanced predictive modeling to better serve its institutional clientele. As the life science sector continues to demand more sophisticated data-driven decision-making tools, BioInetlli's commitment to innovation will be pivotal in maintaining its competitive edge. Future growth initiatives are expected to prioritize the refinement of its market intelligence suite, further cementing its role as an indispensable partner for organizations navigating the complexities of the modern biopharma and research ecosystem.
See full BioInetlli company page
